Lomina AG logo

LOMINA AG group is an international joint venture dedicated to a production of In Vitro Medical Devices.

LOMINA AG group is committed to provide high-quality diagnostic products and services to meet the global healthcare needs and to empower patients to make a critical decision about their health. A significant aim is to assist Health Care Professionals with their challenging world worldwide.

Lomina SuperBiomedical, as a part of LOMINA AG, is dedicated to development and manufacturing of In Vitro Diagnostic Medical Devices (IVD). Such products include more than 500 diferent IVD Rapid Response Tests ranging from Oral Fluid Swab tests trough Full Blood, Serum or Plasma screening immunoassays, responding to a waste range of viral, bacterial, oncological, cardiological and other diseases.

Melianta Limited is the exclusive distributor of the Lomina AG in Ukraine and Cyprus regarding the sale of SARS-CoV-2/COVID-19 tests in the above countries.


Fast COVID-19 IgM / IgG Antibody Detection Kit

(Colloidal gold)

Fast COVID-19 IgM / IgG Antibody Detection Kit

IVD test for self-testing for the detection of IgG and IgM antibodies in the blood, thus demonstrating active or overcome COVID 19 infection caused by SARS-CoV-2 virus. The product does not serve as a primary tool for early detection of COVID19! For these purposes, it is necessary to use PCR methods, antigen assays and the like.

This kit works on the principle of immunochromatography using colloidal gold. The test kit contains 1) An antigen labelled with colloidal gold and a complex of control antibodies. 2) Nitrocellulose membranes with two test strips (M and G-line) and one quality control strip (C-line) marked. To drop the required amount of sample into the hole on the test strip, the sample will flow over the nitrocellulose membrane inside the test strip due to the capillary effect. If the test sample contains SARS-CoV IgM / IgG antibodies, the antibody will bind to the colloidal gold-labelled SARS-CoV-2 antigen and the antibody complex will render monoclonal IgM antibodies, or monoclonal IgG antibodies on the nitrocellulose membrane as purple-red M, or G lines and thus plots whether the samples are positive for IgM or IgG antibodies and thus demonstrates COVID-19 infection, or provides evidence of past infection and active presence of antibodies in the body.

The test is developed and tested for the general public for the use of blood samples taken from a finger.

SARS-CoV-2 (N)protein Antigen rapid test

(Fluorescence Immunochromatics assay)

IVD test for the detection of SARS-CoV-2 Nucleocapsid Protein Antigen presence in a human oropharyngeal swab sample / ie the demonstration possible COVID19 infection.

The kit is used for the qualitative detection of new coronavirus nucleocapsid (N) antigen in human throat swab samples in vitro. It is only used as a supplementary detection indicator for suspected cases of new coronavirus negative nucleic acid detection or used in conjunction with nucleic acid detection in the diagnosis of suspected cases.

The kit is intended for use by healthcare professionals only.

SARS-CoV-2 (N)protein Antigen rapid test